ANDREW WILLIAMS: Open Payments
NPI 1235551292 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 76 payments from 17 companies in 2025. Trend: 2023 $1,984 · 2024 $795 · 2025 $1,506
Food & beverage: $1,304Education: $202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $415 |
| Janssen Biotech, Inc. | 10 | $268 |
| Incyte Corporation | 14 | $188 |
| GENZYME CORPORATION | 7 | $145 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Organon LLC | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Lilly USA, LLC | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Botanix SB Inc | 2 | $39 |
Products named: TREMFYA, DUPIXENT, RINVOQ, OPZELURA, SKYRIZI, TALTZ, Sotyktu, SOFDRA.
Industry payments across TX — which companies pay providers there.
